Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the unaudited financial results ....
RESULTS
● No Immediate Change
LOW RISK
📅 Filed on BSE: 05 Aug 2026, 03:04 PM IST · BSE ID: 511f9db2-1b1d-4c74-9787-868e4c51102c
View Original BSE Filing (PDF)
💡
In Simple Terms
Beryl Drugs Ltd will hold a board meeting on August 11, 2026, to review its financial results for the April-June 2026 quarter.
🤖 AI Summary
- Board of Directors meeting scheduled for Tuesday, August 11, 2026, at 02.00 PM.
- Meeting to consider and approve Unaudited Financial Results for quarter ended June 30, 2026.
- Board will adopt and approve Limited Review Report for the quarter ended June 30, 2026.
- Trading window for company securities closed from July 01, 2026, will open after 48 hours post-meeting.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this board meeting notice.
👤
Who Is Affected
All shareholders of Beryl Drugs Ltd are affected by the forthcoming financial results, which will provide an update on the company's performance for the quarter ended June 30, 2026.
🔍
Management Signal
The scheduled board meeting indicates management's adherence to regulatory timelines for disclosing quarterly financial performance.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
August 11, 2026: Board meeting outcome – Unaudited Financial Results for Q1 FY27.
Post-August 11, 2026: Official disclosure of the Q1 FY27 financial results by the company.
Post-August 13, 2026: Trading window re-opening after 48 hours from conclusion of board meeting.
LOW RISK
This is a routine procedural announcement of an upcoming board meeting.
💡 Investor Takeaway
Beryl Drugs Ltd's Board meeting on August 11, 2026, will primarily focus on approving the unaudited financial results for the quarter ended June 30, 2026, along with adopting the Limited Review Report.
❓ Frequently Asked Questions
When is Beryl Drugs Ltd's Board meeting scheduled?
Beryl Drugs Ltd's Board of Directors meeting is scheduled for Tuesday, August 11, 2026, at 02.00 PM.
What is the primary agenda for Beryl Drugs Ltd's upcoming Board meeting?
The primary agenda for the Board meeting is to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2026, and adopt the Limited Review Report.
When will the trading window for Beryl Drugs Ltd securities reopen?
The trading window for Beryl Drugs Ltd securities, closed since July 01, 2026, will open after 48 hours from the conclusion of the Board Meeting on August 11, 2026.
Questions based on this BSE filing only. For information purposes.